FindTrial
Sign In

Effect of high-flow nasal cannula oxygen therapy on postoperative oxygenation and postoperative pulmonary complications in patients undergoing thoracic surgery

Effect of high-flow nasal cannula oxygen therapy on postoperative oxygenation and postoperative pulmonary complications in patients undergoing thoracic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054029
Enrollment
Unknown
Registered
2021-12-07
Start date
2022-01-09
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic lung resection

Interventions

High-flow nasal cannula oxygen therapy group:High-flow nasal cannula oxygen therapy
Control group:No

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged >= 18 years, elective endoscopic thoracic surgery, ASA grade I or II.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation, obstructive sleep apnea syndrome, had lung transplantation.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;—

Countries

China

Contacts

Public ContactZhang Yang, Gao Ju

Northern Jiangsu People's Hospital

419037882@qq.com+86 18051063040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026